Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spina, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spina, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 10:S87-S90, 1999
© 1999 European Society for Medical Oncology

Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection

M. Spina1, S. Sandri1, D. Serraino2, C. Gobitti3, M. Fasan4, A. Sinicco5, P. L. Garavelli6, A. Ridolfo7, U. Tirelli1 and for the GICAT

1 Division of Medical Oncology Sacco Hospital, Milan
2 Epidemiology Service Sacco Hospital, Milan
3 Division of Radiotherapy, Aviano Cancer Center Sacco Hospital, Milan
4 Division of Infectious Diseases Sacco Hospital, Milan
5 Institute of Infectious Diseases, Hospital Amedeo di Savoia Turin, Italy
6 Division of Infectious Diseases, General Hospital Alessandria
7 Clinic of Infectious Diseases Sacco Hospital, Milan, Italy

Correspondence to: Prof. U. Tirelli, Division of Medical Oncology and AIDS, Centro di Riferimento Oncologico Via Pedemontana 12 33081 Aviano (PN), Italy E-mail: oma{at}ets.it

Incidence and mortality of AIDS patients have significantly declined in the developed countries due to the very active anti-HIV combination therapy available today. Because of the prolongation of the survival expectancy of these patients, other non-AIDS defining tumours have been recently reported in several cohort studies with increased frequency.

We want to report the clinico-pathological features and the outcome of 39 patients with lung cancer and HIV infection, collected by the Italian Cooperative Group on AIDS and Tumors (GICAT) between 1986 and December 1997. As a control group, we decided to evaluate patients, less than 60 years of age, with lung cancer but without HIV infection seen at the CRO, Aviano, during 1995 and 1996.

The median age of the study group patients was 38 years (range 28–58) and 90% of them were males. Sixty-nine percent of patients were intravenous drug users and HIV infection was asyntomatic in 41% of patients. NSCLC was observed in 78% of patients, SCLC in 13% and mesothelioma in 8%. Among NSCLC, adenocarcinoma was the most frequently observed histological subtype (48%). No differences were found as regards the stage of disease at diagnosis and the histologic subtype in comparison with the control group. The median overall survival was significantly shorter for patients with HIV infection when compared to that of the control group (5 months vs. 10 months, P>0.0001).

In conclusion, the outcome of patients with SNCLC and HIV infection seems worse than that of the general population, suggesting a synergistic and/or addictive adverse effect of HIV on the outcome of lung cancer.

HIV infection, lung cancer, non-small cell lung cancer, survival, treatment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.